$105.37
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. The company is headquartered in Lakewood, Colorado and currently employs 730 full-time employees. The firm's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.
Country

US

CEO

Mr. Gary Owens

IPO date

1984

Employees

730

ISIN

US59064R1095

Key stats

Open

$107.29

Volume

395.65K

Market cap

$582.77M

Prev. close

$105.48

Impl / hst vl

-

Open interest

$0.00

$105.16

Day’s Range

$110.13

$71.07

52W Range

$113.99

Valuation

44
Valuation score
Fairly Valued
P/E
72.78
P/S
1.96
P/B
2.62
Current ratio
1.72
Debt / Equity
0.67
ROE
3.71%
Gross margin
66.23%
Income growth
-213.94%
FCF growth
-24.84

Jun

15

Dividends

The last payment date was Jun 15, 2026

Div. per Share

$0.16

Div. Yield

0.15%

Payout Ratio

-

Div. Growth YoY

0.00%

Analysts estimates

Consensus rating
Strong buy

The average rating from top 3 analysts indicates that stock may significantly outperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$114.24
The top 4 analysts forecasts that 12-month price may increase by 8.42%, with a low of $94.94 and a high of $136.50
$94.94
Low
$114.24
Avg
$136.50
High
Current price

Earnings

Q1 ‘26 revenue
$63.72M
Q1 ‘26 net income
-$4.14M
Revenue
Net income
Previous EPS
$0.85
Estimate EPS
$0.16
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply